Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Endocrine Cancers

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    COGADVL1522

    08/02/2016

    A Phase 2 Study of IMGN901 (Lorvotuzumab Mertansine; IND# 126953, NSC# 783609) in Children with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) and Synovial Sarcoma

    Treatment

    VICCMD15110

    04/05/2016

    A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors


    Print this page for your doctor